3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
14
Lung Neoplasms
13
Colorectal Neoplasms
13
Lymphoma
5
Hematologic Neoplasms
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Hematopoietic and Lymphatic System Neoplasm
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Papillomavirus Infections
3
Pancreatic Neoplasms
3
Obesity-Related Malignant Neoplasm
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Neoplasms
2
Multiple Myeloma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Endometrial Neoplasms
2
Breast Carcinoma In Situ
2
Advanced Malignant Solid Neoplasm
2
Vulvar Neoplasms
1
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Early Intervention, Educational
×
1 year
×
Clear all
No trials found.